CliffBio
small molecule

EPANED KIT

ENALAPRIL MALEATE

Loss of exclusivityNovember 2032latest FDA-listed patent expiry
CompanyAzurity Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameEPANED KIT
Active ingredientENALAPRIL MALEATE
Strength1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formFOR SOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalAugust 2013
Marketing statusDISCN

Listed patents

PatentExpiresType
8778366November 2032use U-1892
9968553November 2032use U-1723
8568747November 2032product
9855214November 2032product

More from Azurity Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

EPANED KIT patent cliff — loss of exclusivity November 2032 | CliffBio